Clinical Trials Directory

Trials / Completed

CompletedNCT03532789

Herbal Patch for Overactive Bladder

Clinical Evaluation of Herbal Patch for Overactive Bladder Patients

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
66 (actual)
Sponsor
En Chu Kong Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis.

Detailed description

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis. The 1st year project: (1) Expect to enroll 62 clinical subjects of OAB. (2) Evaluate subjects 'symptom and proceed patch treatment. (3) Record treatment responses including adverse effect. (4) Conduct statistically analysis. The 2nd year project: (1) Completing enrollment of 62 clinical subjects of OAB. (2) Finish evaluation and treatment of all subjects. (3) Statistically analysis all collecting data (4) Discuss and analyze the outcome.

Conditions

Interventions

TypeNameDescription
DRUGherbal patchOne patch with medicine should be applied to the skin every other day within two weeks
DRUGplacebo patchOne patch without medicine should be applied to the skin every other day within two weeks

Timeline

Start date
2018-05-14
Primary completion
2019-10-23
Completion
2019-10-23
First posted
2018-05-22
Last updated
2019-10-25

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03532789. Inclusion in this directory is not an endorsement.